Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
8.36 USD | +3.21% | -9.48% | +3.32% |
06-01 | Transcript : Iovance Biotherapeutics, Inc. - Special Call | |
05-13 | Truist Securities Trims Iovance Biotherapeutics' Price Target to $25 From $26, Buy Rating Maintained | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.32% | 2.27B | |
+12.61% | 3.43B | |
-19.19% | 2.03B | |
-19.50% | 1.63B | |
+32.60% | 1.16B | |
+16.92% | 714M | |
-9.39% | 703M | |
-23.27% | 500M | |
-1.29% | 279M | |
-15.53% | 161M |
- Stock Market
- Equities
- IOVA Stock
- News Iovance Biotherapeutics, Inc.
- Baird Adjusts Iovance Biotherapeutics Price Target to $23 From $20, Maintains Outperform Rating